微信

 
 

师资队伍

当前位置：

李廷栋

李廷栋 高级工程师

职务：

电子邮件：litingdong@xmu.edu.cn

办公地点：厦门大学翔安校区国家传染病诊断试剂与疫苗工程技术研究中心(椭圆楼)253

主要研究领域：

李廷栋，理学博士，高级工程师

教育经历

2014年毕业于厦门大学生命科学学院生物化学与分子生物学专业，获理学博士学位；

2006年毕业于厦门大学生命科学学院生物技术专业，获理学学士学位；

工作经历

2015年起任职bet体育365官网正规国家传染病诊断试剂与疫苗工程技术研究中心。


主要研究方向

  1. 轮状病毒基因工程疫苗的研究；

  2. EB病毒与鼻咽癌发生、发展的关系的研究；

  3. 人巨细胞病毒流行病学及先天性感染风险评估方法的研究。

通信地址：厦门大学翔安校区国家传染病诊断试剂与疫苗工程技术研究中心(椭圆楼)253

邮编：361102

电子邮箱: litingdong@xmu.edu.cn

代表性论文

  1. Li Y, Xue M,Yu L, Luo G, Yang H, Jia L, Zeng Y, Li T*, Ge S* and Xia N, Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine. Vaccine, 2018. 36(16): p. 2086-2092.

  2. Li T#, Guo X#, Ji M#, Li F, Wang H, Cheng W, Chen H, Ng M, Ge S*, Yuan Y*, and Xia N, Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma. Cancer Med, 2018. 7(4): p. 1458-1467.

  3. Zhang, C, Huang X, Chen S, Li Y, Li Y, Wang X, Tang J, Xia L, Lin Z, Luo W, Li T, Li S, Zhang J, Xia N*, and Zhao Q*, Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid. Vaccine, 2018. 36(45): p. 6761-6771.

  4. Huang Y#, Guo X#, Song Q#, Wang H, Yu H, Zhang Y, Qiao E, Xue W, Li X, Zhuang S, Wei F, Li T, Ge S, Wu T, Xia N, and Zhang J*, Cytomegalovirus Shedding in Healthy Seropositive Female College Students: A 6-Month Longitudinal Study. J Infect Dis, 2018. 217(7): p. 1069-1073.

  5. Li, T, Li J, Huang X, Wang H, Guo X, Ge S*, and Zhang J*, Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population. Eur J Clin Microbiol Infect Dis, 2017. 36(5): p. 863-868.

  6. Huang, X, Li J, Ge S*, Li T, Wang H, Guo X, Fu T, and Zhang J, Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen. Journal of Virological Methods, 2017. 240: p. 21-25.

  7. Xue, M, Yu L, Jia L, Li Y, Zeng Y, Li T*, Ge S*, and Xia N, Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model. Hum Vaccin Immunother, 2016. 12(11): p. 2959-2968.

  8. Xue M, Yu L, Che Y, Lin H, Zeng Y, Fang M, Li T*, Ge S*, Xia N. Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate. Vaccine 2015; 33:2606-13.

  9. Li T, Lin H, et al. Development of an Enzyme-Linked Immunospot (Elispot) Assay for determination of rotavirus infectivity [J]. JVM, 2014, 209: 7-14.

  10. Li T, Lin H, Zhang Y, et al. Improved characteristics and protective efficacy in an animal model of E. coli-derived recombinant double-layered rotavirus virus-like particles [J]. Vaccine, 2014, 32(17):1921-1931.